Zota Health Care Latest Share Price (ZOTA)
TODAY IN ONE LINE
ZOTA fell 1.6% on above-average volume (1.6x avg), lagging Nifty's 0.5% move, supported by recent strong earnings.
With a market cap of ₹3,736.86 Cr., it trades at a P/E of -35.61. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Zota Health Care flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
No red flags identified
Latest Zota Health Care News
What changed recently?
Recent events, corporate actions, and announcements.
Zota Health Care Ltd valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Zota Health Care Ltd, framed against the sector median so the premium or discount is obvious at a glance.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Zota Health Care Ltd technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Zota Health Care Ltd — derived from the latest tape, not yesterday's close.
Zota Health Care Ltd last traded at ₹1,076.8 with an intraday range of ₹1,069.5–₹1,109.6 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹1076.80| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 1181.30 | +104.50 | +9.70% |
| R3 | 1141.20 | +64.40 | +5.98% |
| R2 | 1125.40 | +48.60 | +4.51% |
| R1 | 1101.10 | +24.30 | +2.26% |
| PIVOT | 1085.30 | 8.50 | 0.79% |
| CURRENT | 1076.80 | — | — |
| S1 | 1061.00 | -15.80 | -1.47% |
| S2 | 1045.20 | -31.60 | -2.93% |
| S3 | 1020.90 | -55.90 | -5.19% |
| S4 | 980.80 | -96.00 | -8.92% |
ZOTA is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹1086.9–₹1102.7
Trading Below opening range, showing Bearishness
Zota Health Care Ltd financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Zota Health Care Ltd — consolidated or standalone — with margins, YoY growth and key ratios inline.
Zota Health Care Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹3,736.86 Cr. and reported EPS of ₹-30.60.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 293 | 539 ▲ 83.9% |
| Sales Growth YoY %Derived | 62.32% | 83.86% |
| Other Income | 2 | 7 ▲ 259.6% |
| Total Income | 295 | 546 ▲ 85.1% |
| 137 | 214 ▲ 55.8% | |
| Gross ProfitDerived | 156 | 325 ▲ 108.6% |
| Gross Margin %Derived | 53.13% | 60.28% |
| 161 | 306 ▲ 89.7% | |
| EBITDA (Operating Profit)Derived | -6 | 19 ▲ 423.4% |
| OPM %Derived | -1.96% | 3.44% |
| 54 | 94 ▲ 73.8% | |
| Profit Before Tax (PBT) | -58 | -80 ▼ 38.5% |
| -1 | -6 ▼ 536.1% | |
| Effective Tax %Derived | 1.57% | 7.21% |
| Total Profit for Period | -57 | -74 ▼ 30.6% |
| Less: Non-controlling Interests | -0 | -0 ▲ 58.5% |
| Net Profit (Owner's PAT)Derived | -56 | -74 ▼ 31.1% |
| Net Profit Margin %Derived | -19.25% | -13.73% |
| PAT Growth YoY %Derived | -293.08% | -31.10% |
| Earnings Per Share (EPS ₹) | -19.70 | -21.35 ▼ 8.4% |
| Diluted Shares Outstanding (Cr) | 3 | 3 ▲ 20.9% |
| Other Comprehensive Income (Net of Tax) | 0 | 2 ▲ 407.9% |
| Total Expenses (incl. D&A & Interest) | 353 | 626 ▲ 77.5% |
| Material Cost % of RevenueDerived | 5.54% | 3.24% |
| Employee Cost % of RevenueDerived | 29.38% | 33.11% |
| Other Cost % of RevenueDerived | 25.71% | 23.73% |
| Interest Coverage (x)Derived | -4.54x | -3.68x |
| Period | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 95 | 107 ▲ 12.3% | 131 ▲ 22.9% | 140 ▲ 6.7% | 180 ▲ 29.0% | 293 ▲ 62.3% | 539 ▲ 83.9% | |
| Sales Growth YoY %Derived | — | 12.28% | 22.85% | 6.68% | 28.96% | 62.32% | 83.86% | |
| Other Income | 2 | 1 ▼ 16.7% | 2 ▲ 29.4% | 2 ▲ 20.0% | 1 ▼ 40.9% | 2 ▲ 78.9% | 7 ▲ 259.6% | |
| Total Income | 97 | 108 ▲ 11.8% | 133 ▲ 22.9% | 142 ▲ 6.8% | 182 ▲ 28.0% | 295 ▲ 62.4% | 546 ▲ 85.1% | |
66 | 73 ▲ 10.5% | 87 ▲ 18.2% | 83 ▼ 3.9% | 97 ▲ 16.1% | 137 ▲ 42.0% | 214 ▲ 55.8% | ||
| Gross ProfitDerived | 29 | 34 ▲ 16.3% | 45 ▲ 33.1% | 57 ▲ 27.2% | 84 ▲ 47.8% | 156 ▲ 85.8% | 325 ▲ 108.6% | |
| Gross Margin %Derived | 30.29% | 31.37% | 33.98% | 40.50% | 46.42% | 53.13% | 60.28% | |
24 | 33 ▲ 35.3% | 30 ▼ 9.4% | 49 ▲ 65.7% | 76 ▲ 54.5% | 161 ▲ 111.7% | 306 ▲ 89.7% | ||
| EBITDA (Operating Profit)Derived | 5 | 1 ▼ 86.2% | 15 ▲ 2268.9% | 7 ▼ 50.4% | 8 ▲ 3.0% | -6 ▼ 175.9% | 19 ▲ 423.4% | |
| OPM %Derived | 4.75% | 0.58% | 11.28% | 5.24% | 4.19% | -1.96% | 3.44% | |
2 | 4 ▲ 98.8% | 4 ▼ 7.3% | 15 ▲ 277.2% | 25 ▲ 65.2% | 54 ▲ 117.0% | 94 ▲ 73.8% | ||
| Profit Before Tax (PBT) | 4 | -0 ▼ 109.5% | 12 ▲ 3503.1% | -5 ▼ 137.7% | -16 ▼ 244.6% | -58 ▼ 256.6% | -80 ▼ 38.5% | |
1 | -0 ▼ 114.0% | 4 ▲ 2353.8% | 1 ▼ 69.3% | -2 ▼ 267.8% | -1 ▲ 50.1% | -6 ▼ 536.1% | ||
| Effective Tax %Derived | 29.01% | 42.83% | 28.37% | -23.06% | 11.23% | 1.57% | 7.21% | |
| Total Profit for Period | 3 | -0 ▼ 107.6% | 9 ▲ 4364.0% | -6 ▼ 164.8% | -14 ▼ 148.5% | -57 ▼ 295.5% | -74 ▼ 30.6% | |
| Less: Non-controlling Interests | — | — | — | — | — | -0 | -0 ▲ 58.5% | |
| Net Profit (Owner's PAT)Derived | 3 | -0 ▼ 107.6% | 9 ▲ 4364.0% | -6 ▼ 164.8% | -14 ▼ 148.5% | -56 ▼ 293.1% | -74 ▼ 31.1% | |
| Net Profit Margin %Derived | 2.88% | -0.20% | 6.79% | -4.12% | -7.95% | -19.25% | -13.73% | |
| PAT Growth YoY %Derived | — | -107.62% | 4,364.05% | -164.81% | -148.54% | -293.08% | -31.10% | |
| Earnings Per Share (EPS ₹) | 1.12 | -0.09 ▼ 108.0% | 3.54 ▲ 4033.3% | -2.29 ▼ 164.7% | -5.55 ▼ 142.4% | -19.70 ▼ 255.0% | -21.35 ▼ 8.4% | |
| Diluted Shares Outstanding (Cr) | 2 | 2 ▲ 0.0% | 3 ▲ 2.4% | 3 ▲ 0.0% | 3 ▲ 2.7% | 3 ▲ 10.8% | 3 ▲ 20.9% | |
| Other Comprehensive Income (Net of Tax) | 0 | 0 ▲ 13.7% | 0 ▼ 1.3% | 0 ▲ 100.1% | 0 ▼ 33.6% | 0 ▲ 64.3% | 2 ▲ 407.9% | |
| Total Expenses (incl. D&A & Interest) | 93 | 108 ▲ 16.9% | 120 ▲ 11.0% | 147 ▲ 21.8% | 198 ▲ 34.9% | 353 ▲ 78.3% | 626 ▲ 77.5% | |
| Material Cost % of RevenueDerived | 13.71% | 18.91% | 15.22% | 12.44% | 7.08% | 5.54% | 3.24% | |
| Employee Cost % of RevenueDerived | 10.87% | 8.71% | 7.81% | 9.23% | 16.87% | 29.38% | 33.11% | |
| Other Cost % of RevenueDerived | 14.67% | 22.07% | 14.89% | 26.04% | 25.37% | 25.71% | 23.73% | |
| Interest Coverage (x)Derived | 34.84x | -23.17x | 34.69x | -1.80x | -2.62x | -4.54x | -3.68x |
Zota Health Care segment analysis : revenue and profit mix.
Disclosed business segments at Zota Health Care with their share of revenue and profit, switchable between consolidated and standalone reporting.
Zota Health Care discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Zota Health Care Ltd.
Our AI distills the core fundamental drivers supporting Zota Health Care Ltd, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Zota Health Care Ltd's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Quarterly sales growth of 67.80% YoY demonstrates exceptional top-line momentum and market traction.
5-year revenue CAGR of 25.23% showcases sustained, consistent growth across business cycles.
Diversified product portfolio spanning generics, OTC, Ayurveda, and nutraceuticals reduces segment risk.
DAVAINDIA retail chain provides direct-to-consumer channel, enhancing brand visibility and margins.
Promoter holding of 49.4% signals stable insider confidence and long-term commitment to company.
Key Risks.
Operating margin of 3.44% (latest quarterly) indicates severely compressed profitability and weak pricing power.
Latest quarterly EPS of -₹21.4 reflects fundamental unprofitability and severe capital destruction.
Negative ROE of -15.00% and ROCE of -8.47% demonstrate severe capital inefficiency and value destruction.
Operating cash flow persistently negative, signaling persistent cash burn and operational distress.
EV/EBITDA of 189.85x far exceeds pharmaceutical peer median, indicating severe overvaluation.
Flip Conditions.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Income thesis breaks if the dividend is cut or yield falls below 0.04%.
Zota Health Care Ltd peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Zota Health Care Ltd is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Zota Health Care Ltd chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Zota Health Care Ltd — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Zota Health Care Ltd delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Zota Health Care Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Zota Health Care Ltd stood at 63.9% of traded volume, against a 20-day average of 59.4%.
Zota Health Care announcements: results, concalls, ratings, M&A.
Filings Zota Health Care sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Zota Health Care files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 190 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
Zota Health Care LImited has informed the Exchange about Transcript
Copy of Newspaper Publication
Zota Health Care Limited has informed the Exchange about Copy of Newspaper Publication
Analysts/Institutional Investor Meet/Con. Call Updates
Zota Health Care Limited has informed the Exchange about Audio Recording Link of Earnings Conference Call on financial results for the quarter ended…
Monitoring Agency Report
Monitoring Agency Report issued by CRISIL Ratings Limited for the utilization of funds raisedthrough Qualified Institutional Placement for quarter…
Investor Presentation
Zota Health Care LImited has informed the Exchange about Investor Presentation
Investor decks & rating reports.
Zota Health Care dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Zota Health Care has declared, sequenced by announce and record date.
Zota Health Care corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
Zota Health Care insider trading: promoter and management activity.
Promoter, director and designated-employee transactions in Zota Health Care as reported to SEBI — buying and selling signals from the people who know the business best.
Zota Health Care insider activity below tracks 5 reported promoter, director and designated-employee transactions under SEBI Regulation 7(2).
| Insider | Category | Txn Date | Action | Quantity | Value (₹) | Price |
|---|---|---|---|---|---|---|
| KENVI ZOTA | Insider | 17 Mar 2025 | buy | +95.0 K | ₹7.36 Cr. | ₹774.45 |
| HIMANSHU MUKTILAL ZOTA | Insider | 17 Mar 2025 | sell | −97.2 K | ₹7.53 Cr. | ₹774.67 |
| VINODCHANDRA DHIRAJLAL MEHTA | Insider | 20 Dec 2024 | sell | −2.0 K | ₹15.61 L | ₹780.61 |
| NIRUBEN VINODKUMAR MEHTA | Insider | 02 Dec 2024 | sell | −6.1 K | ₹36.95 L | ₹608.50 |
| VINODCHANDRA DHIRAJLAL MEHTA | Insider | 02 Dec 2024 | buy | +6.1 K | ₹36.95 L | ₹608.50 |
About Zota Health Care Ltd: business, sector, key facts.
What Zota Health Care Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Zota Health Care Ltd operates in the Pharmaceuticals industry under the Healthcare sector, listed as NSE: ZOTA.
Zota Health Care Limited is a pharmaceutical company headquartered in Surat, India, established in 1995. Its core business revolves around the development, manufacturing, and marketing of a diverse range of pharmaceutical products both domestically within India and internationally.
The company's product portfolio is extensive and caters to a broad spectrum of healthcare needs. This includes a significant presence in the generic drug market, offering affordable alternatives to branded medications. Beyond generics, Zota also manufactures and markets wellness products, over-the-counter (OTC) medications readily available without a prescription, and products rooted in traditional Ayurvedic medicine and the increasingly popular nutraceutical sector. This diversified approach allows them to tap into various segments of the healthcare market.
A key focus for Zota is addressing chronic illnesses prevalent globally. Their product line specifically includes medications designed to manage and treat conditions such as diabetes, heart disease, and thyroid disorders. This concentration on chronic care highlights a commitment to providing essential therapies for long-term health management.
In addition to its wholesale and export operations, Zota also has a retail presence in India. Operating under the brand name DAVAINDIA, these retail stores provide a direct-to-consumer channel for the company's products, enhancing brand visibility and facilitating direct customer engagement.
In summary, Zota Health Care Limited is a multifaceted pharmaceutical company with a substantial presence in India and international markets. Its strategic diversification across various product categories, including generics, wellness, OTC, Ayurvedic, and nutraceutical products, coupled with its retail and export operations, positions it for continued growth and success in the dynamic healthcare industry.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- 3B Blackbio DX (3BBLACKBIO) Share PricePeer
- Abbott India (ABBOTINDIA) Share PricePeer
- Acutaas Chemicals (ACUTAAS) Share PricePeer
- Anlon Healthcare (AHCL) Share PricePeer
- Amanta Healthcare (AMANTA) Share PricePeer
- Stocks near 52-week low (reversal watch)Screener
- Reversal Hunter strategy playbookStrategy
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
Questions investors ask about Zota Health Care Ltd (ZOTA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Zota Health Care Ltd (ZOTA)?
The current share price of Zota Health Care Ltd (ZOTA) is ₹1,076.80. Today, the stock has declined by ₹17.70 (1.62%), trading in a range of ₹1,069.50 to ₹1,109.60. The stock opened at ₹1,086.90 with a trading volume of 1,10,375 shares.
02Is Zota Health Care Ltd stock a good investment for long-term?
Zota Health Care Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹3,736.86 Cr., P/E ratio of -35.61, ROE of -15%, and ROCE of -8.47%. The dividend yield stands at 0.09%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Zota Health Care Ltd stock?
The 52-week high price of Zota Health Care Ltd (ZOTA) is ₹1,740.00, while the 52-week low is ₹1,026.20. Currently trading at ₹1,076.80, the stock is 4.93% above its 52-week low and 38.11% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Zota Health Care Ltd stock at the current price?
Whether to buy Zota Health Care Ltd stock at ₹1,076.80 depends on multiple factors. The stock is currently trading with a P/E ratio of -35.61 and P/B ratio of 5.44. Today's performance shows a loss of 1.62%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Zota Health Care Ltd and when is the next dividend?
Zota Health Care Ltd offers a dividend yield of 0.09%, which means for every ₹100 invested at the current price of ₹1,076.80, you can expect to receive approximately ₹0.09 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Zota Health Care Ltd?
Zota Health Care Ltd's key financial metrics include: P/E Ratio: -35.61, P/B Ratio: 5.44, ROE: -15%, ROCE: -8.47%, Dividend Yield: 0.09%, EPS: ₹-30.60, Book Value: ₹200.00, and Debt-to-Equity: 0.39. The company's market cap stands at ₹3,736.86 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Zota Health Care Ltd stock performing today in the market?
Zota Health Care Ltd stock opened at ₹1,086.90 and is currently trading at ₹1,076.80, showing a decline of ₹17.70 (1.62%). The intraday high is ₹1,109.60 and low is ₹1,069.50. The trading volume stands at 1,10,375 shares, indicating moderate market participation today.
08What is the P/E ratio of Zota Health Care Ltd and what does it indicate?
Zota Health Care Ltd has a Price-to-Earnings (P/E) ratio of -35.61, which means investors are willing to pay -35.61 for every ₹1 of earnings. With an EPS of ₹-30.60, this P/E ratio suggests the stock may be undervalued or facing growth challenges. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Zota Health Care Ltd (ZOTA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.